As a well‐acknowledged malignant factor that drives PCa initiation and progression,9, 52 AR exerts its oncogenic function mainly by transcriptionally binding on the promoter or enhancer of its target genes and stimulating their expression, further stimulating the AR signaling pathway.53 This evidence concerns the gene AR and posterior cortical atrophy.